Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722
Bristol-Myers Squibb
Tony Mok; Kazuhiko Nakagawa; Keunchil Park; Yuichiro Ohe; Nicolas Girard; Hye Ryun Kim; Yi-Long Wu; Justin Gainor; Se-Hoon Lee; Chao-Hua Chiu; Sang-We Kim; Cheng-Ta Yang; Chien Liang Wu; Lin Wu; Meng-Chih Lin; Jens Samol; Kazuya Ichikado; Mengzhao Wang; Xiaoqing Zhang; Judi Sylvester; Sunney Li; Ann Forslund; James Chih-Hsin Yang